Brent Egan to Tetrazoles
This is a "connection" page, showing publications Brent Egan has written about Tetrazoles.
Connection Strength
0.759
-
From TROPHY with pride. Am J Hypertens. 2007 Mar; 20(3):342-3; author reply 343-5.
Score: 0.263
-
Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide? J Clin Hypertens (Greenwich). 2012 Jul; 14(7):415-21.
Score: 0.094
-
Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients. J Clin Hypertens (Greenwich). 2011 Oct; 13(10):731-8.
Score: 0.089
-
Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. J Hypertens. 2010 Aug; 28(8):1761-9.
Score: 0.083
-
An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY). J Clin Hypertens (Greenwich). 2008 Jun; 10(6):436-42.
Score: 0.072
-
Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006 Apr 20; 354(16):1685-97.
Score: 0.061
-
Trial of preventing hypertension: design and 2-year progress report. Hypertension. 2004 Aug; 44(2):146-51.
Score: 0.055
-
In prehypertension leukocytosis is associated with body mass index but not with blood pressure or incident hypertension. J Hypertens. 2014 Feb; 32(2):251-9.
Score: 0.027
-
Does life-long reduction in low-density lipoprotein cholesterol reduce the risk of new-onset hypertension? Am J Cardiol. 2006 Oct 15; 98(8):1122.
Score: 0.016